BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10907029)

  • 1. [Hypercoagulation in patients with nephrotic syndrome].
    Zdrojewski Z; Raszeja-Specht A; Skibowska A; Owczarzak A; Rutkowski B
    Pol Merkur Lekarski; 1997 Jan; 2(9):201-4. PubMed ID: 10907029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
    Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
    Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet defects in chronic myeloproliferative disorders].
    Raszeja-Specht A; Skibowska A; Kabata J; Hellmann A
    Acta Haematol Pol; 1994; 25(3):253-60. PubMed ID: 7992598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
    Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic risks and complications in nephrotic children.
    Schlegel N
    Semin Thromb Hemost; 1997; 23(3):271-80. PubMed ID: 9255908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of platelet membrane structure in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Nowak J; Raszeja-Specht A; Skibowska A; Kustosz J; Rutkowski B
    Przegl Lek; 1996; 53(5):431-3. PubMed ID: 8754408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carotid artery thrombosis and myocardial infarction in nephrotic syndrome].
    Nigond J; Grolleau-Raoux R
    Arch Mal Coeur Vaiss; 1990 Jan; 83(1):105-8. PubMed ID: 2106297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The evaluation of hemostatic disorders in patients with systemic lupus erythematosus].
    Arshinov AV; Lapin VA; Raĭt IuA
    Ter Arkh; 1999; 71(5):38-40. PubMed ID: 10399229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome.
    Vaziri ND; Paule P; Toohey J; Hung E; Alikhani S; Darwish R; Pahl MV
    Arch Intern Med; 1984 Sep; 144(9):1802-3. PubMed ID: 6477000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet aggregation and various coagulation parameters in liver cirrhosis].
    Calabrese S; Giansante C; Sammartini C; Benedetti A
    Minerva Med; 1984 Apr; 75(18):1047-52. PubMed ID: 6728255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of renal vein thrombosis in patients with nephrotic syndrome: a prospective study].
    Cheng H
    Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):416-9, 447. PubMed ID: 1330232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anomalies of coagulation and thromboembolic complications of nephrotic syndromes].
    Rostoker G; Gouault-Heilmann M; Lang P; Lagrue G
    Pathol Biol (Paris); 1987 Feb; 35(2):195-9. PubMed ID: 3550633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemostatic function changes in Singapore women using Norplant implants: a four year review.
    Singh K; Viegas OA; Ratnam SS
    Adv Contracept Deliv Syst; 1991; 7(2):147-56. PubMed ID: 12284217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombosis and disorders of hemostasis in nephrotic syndrome].
    Kanfer A
    Nephrologie; 1992; 13(4):151-7. PubMed ID: 1407255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of impaired fibrin polymerization in patients with the nephrotic syndrome.
    Mysliwiec M; Ralston A; Ackrill P; Poller L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):73-8. PubMed ID: 1695187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombotic factors in nephrotic syndrome.
    Saxena R; Batra VV; Singh ND
    Indian J Pathol Microbiol; 2000 Jul; 43(3):319-23. PubMed ID: 11218679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome].
    Rowiński M; Rydzewski A; Małyszko JS; Małyszko J; Myśliwiec M
    Przegl Lek; 1994; 51(2):77-81. PubMed ID: 8058973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclophosphamide efficacy in maintenance therapy of nephrotic syndrome in patients with chronic glomerulonephritis].
    Ter Arkh; 2004; 76(9):26-8. PubMed ID: 15532372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.